Your Genetic Disease Assay Development Starts Here:
Take the Straight Line
TessArae can speed the development of your custom genetic disease assay. Screen an individual genome for hundreds of known mutations underlying dozens of disorders. All in a fraction of the time and cost of Sanger or next-gen sequencing.
TessArae’s platform generates genomic DNA sequence. Automated data analysis eliminates your bioinformatics burden. Nucleotide sequence results are listed gene-by-gene, mutation-by-mutation, in an easy-to-read format. Our proprietary technology helps you identify known single base mutations (SNPs or polymorphisms), as well as insertions and deletions.
From extracted genomic DNA to a list of detected mutations in less than 24 hours. TessArae enables you to create the fastest multiplexed sequencing assays available today.
TessArae's proprietary platform and enhanced data analysis algorithms simplify your development and implementation process. They also make your genetic disease assay simpler to run. Results are provided within 10 minutes of assay completion as a list of detected mutations, eliminating the labor-intensive bioinformatics burden of Sanger and next-gen sequencing.
At half the cost of Sanger sequencing and significantly less cost than next-gen, the TessArae solution helps you develop a more comprehensive test at much less expense without sacrificing quality.
"Implementation of the custom designed resequencing solution from TessArae, which simultaneously detects all known mutations and screens for mis-sense mutations in eight genes of the RAS/MAPK pathway, allows GeneDx to offer a more comprehensive test than we could previously, yet at significantly lower cost and with much faster turnaround time."
Dr. John Compton, GeneDx Co-President, Scientific Director
GeneDx Took the Straight Line See Where it Took Them